Amicus Therapeutics Inc (NASDAQ:FOLD)
| 21.10 Delayed Data As of Jan 22 |  +0.88 / +4.35%Today’s Change | 6.25 Today|||52-Week Range 25.39 | -8.62% Year-to-Date |
Latest FOLD News | Press Releases
No recent news for Amicus Therapeutics Inc.
Today’s Trading
| Previous close | 20.22 |
| Today’s open | 19.70 |
| Day’s range | 19.70 - 21.20 |
| Volume | 123,137 |
| Average volume (3 months) | 2,344,336 |
| Market cap | $5.5B |
Data as of 3:59pm ET, 01/22/2021
Growth & Valuation
| Earnings growth (last year) | +21.08% |
| Earnings growth (this year) | +31.07% |
| Earnings growth (next 5 years) | -85.64% |
| Revenue growth (last year) | +99.72% |
| P/E ratio | NM |
| Price/Sales | 12.85 |
| Price/Book | 11.31 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| SAGESAGE Therapeutics In... | -3.77 | -4.08% |
| PRGOPerrigo Company PLC | -0.13 | -0.30% |
| HCMHutchison China Medi... | +0.88 | +2.64% |
| GRFSGrifols SA | -0.28 | -1.45% |
Data as of 3:59pm ET, 01/22/2021
Financials
| Next reporting date | March 3, 2021 |
| EPS forecast (this quarter) | -$0.23 |
| Annual revenue (last year) | $182.2M |
| Annual profit (last year) | -$356.4M |
| Net profit margin | -195.56% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Cranbury, New Jersey |
Forecasts
